TNFSF10 and neoplasm: The pharmacokinetics of intratumorally administered therapeutics is not yet well understood and characterized, and these studies shed new light on how soluble TRAIL responds within the compact tumor environment.[35] We further explore the mechanoresponse of PCa cells to FUS‐mediated therapy to provide methods that can overcome drug resistance in cancer and enhance therapeutic efficacy.